Pharmacological characterization of novel marine toxins
Pharmacological characterization of novel marine toxins
批准号:
6936778
负责人:
JAMES M SANDERS
金额:
$2.67万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-02-26 至 2006-01-31
关键词:
aminoacid analogchemical modelsdrug discovery /isolationexcitatory aminoacidglutamate receptorlaboratory mousemarine toxinsneuropharmacologyneurotoxicologypredoctoral investigatorprotein bindingprotein structure functionradiotracersensory receptorssite directed mutagenesistissue /cell culturevoltage /patch clamp
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTIO,N (provided by applicant): Natural source compounds have been critical for the elucidation of glutamate receptor (GluR) function and classification. Excitatory amino acids derived from the manne sponges, such as dysiderbaine (DH), have proven to be valuable tools for characterizing GluRs. This project will determine the pharmacological profile of neoDH (a natural analog of DH) and MSVIII-19 (an intermediate of DH synthesis) on glutamate receptors. Preliminary experiments show, analogues of DH activate kainite receptors selectively and antagonize KA and AMPA receptors (neoDH and MSVIII-19, respectively). Further characterization of the marine toxins will involve testing the compounds on an array of receptors including both ionotropic and metabotropic GluRs. Pharmacological profiling of these compounds is critical to determine the structural components that confer GluR specificity in tandem, homology modeling of KAR subunits with DH and the analogs bound will be utilized to determine the amino acid residues critical for the binding and selectivity of the toxins. The characterization of these compounds will facilitate future modification in design and synthesis of selective GluR compounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金